• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PIQ
Click for more information
6.47% 65.0¢

PROTEOMICS INTERNATIONAL LABORATORIES LTD

Market Cap $85.15M  ! watchlist Created with Sketch. Add to my watchlist
Technology Scientific & Technical Instruments

Proteomics International Laboratories Ltd is an Australia-based medical technology... Proteomics International Laboratories Ltd is an Australia-based medical technology company. The Company is engaged in predictive diagnostics and bioanalytical services. It specializes in the area of proteomics, the industrial scale study of the structure and function of proteins. It focuses on developing and commercializing diagnostic tests for chronic diseases. Its principal activities fall into three key areas: commercialization of PromarkerD, the predictive test for diabetic kidney disease (DKD) and future kidney function decline in patients with type 2 diabetes; precision diagnostic tests in development: the Promarker pipeline, and specialist accredited analytical services on a commercial basis. Its Promarker pipeline and analytical services include PromarkerEndo, PromarkerEso and OxiDx technology. PromarkerEndo is a prototype diagnostic test for endometriosis identified up to 90% of patients with the disease. PromarkerEso is a prototype diagnostic test for esophageal cancer.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PIQ
Webinar- Commercialise Test with Dr Richard Lipscombe 		04/10/24 2 700
04/10/24 Last post  peppers01 Comments Created with Sketch.  2  Views Created with Sketch.  700 
PIQ
Ann: Esophageal cancer diagnostic delivers excellent results 		28/09/24 15 5.9K
28/09/24 Last post  sharpdk Comments Created with Sketch.  15  Views Created with Sketch.  5.9K 
PIQ
Ann: Annual Report to shareholders 		25/09/24 22 11K
25/09/24 Last post  paulstocks Comments Created with Sketch.  22  Views Created with Sketch.  11K 
PIQ
Ann: Initial Director's Interest Notice 		20/09/24 0 300
20/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  300 
PIQ
Ann: Investor Presentation 		19/09/24 3 1.6K
19/09/24 Last post  Floyd2 Comments Created with Sketch.  3  Views Created with Sketch.  1.6K 
PIQ
Ann: Update on commercialisation of PromarkerD in the USA 		16/09/24 42 20K
16/09/24 Last post  Floyd2 Comments Created with Sketch.  42  Views Created with Sketch.  20K 
PIQ
Ann: Appointment of Director 		16/09/24 1 807
16/09/24 Last post  Cloudofsparrows Comments Created with Sketch.  1  Views Created with Sketch.  807 
PIQ
Ann: Notification of cessation of securities - PIQ 		27/08/24 0 346
27/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  346 

See All Discussions arrow Created with Sketch.

Timeline

Esophageal cancer diagnostic delivers excellent results
23 Sep 08:29
 
Initial Director's Interest Notice
20 Sep 10:55
 
Investor Presentation
19 Sep 08:25
 
Appointment of Director
16 Sep 08:20
 
Update on commercialisation of PromarkerD in the USA
11 Sep 08:16
 
Notification of cessation of securities - PIQ
27 Aug 10:30
 
View More arrow Created with Sketch.

Featured News

LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
NEWS Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
right-arrow Created with Sketch.
CC9 Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
right-arrow Created with Sketch.
NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
NEWS Large-scale copper discovery confirmed with high-grade assays—significant potential for major sedimentary-hosted copper deposits
right-arrow Created with Sketch.

(20min delay)
Last
65.0¢ 		Change
-0.045(6.47%) 		Mkt cap ! $85.15M
Open High Low Value Volume
68.5¢ 68.5¢ 65.0¢ $98.86K 149.5K

Buyers (Bids)

No. Vol. Price($)
8 36446 65.0¢
 

Sellers (Offers)

Price($) Vol. No.
66.0¢ 5290 1
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
Last
65.5¢ 		  Change
-0.045 ( 3.68 %)
Open High Low Volume
68.0¢ 68.0¢ 65.5¢ 33178
Last updated 14.08pm 04/10/2024 ?
PIQ (ASX) Chart

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Solstice Minerals (ASX:SLS) shares were up nearly 2.5% in afternoon trades on Friday as it announced drilling plans at Yarri.
Cokal upgrades infrastructure for BBM ramp-up in Indonesia Cokal Ltd has signed an agreement to facilitate greater haulage capacity from its BBM mine in Indonesia, and boosted bridge infrastructure
Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation After just over a week, the thrill China’s latest stimulus announcements put into world markets has started to subside.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Neurotech knocked back by FDA as agency declares target condition not rare enough for special status Neurotech International (NTI) has flagged to its shareholders that the FDA hasn't granted its product NTI164 orphan drug status.

Featured News

NEWS Waroona Project financing strategy aims for non-dilutive funding solutions - discover how this approach will support its Stage One development
right-arrow Created with Sketch.
NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
NEWS High-grade drill results confirm extension at Paddy’s Lodes—reinforcing significant discovery and growth potential at Youanmi Gold Project
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.